Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 18 October 2011
Vol. 4, Issue 195, p. ec293
[DOI: 10.1126/scisignal.4195ec293]


Virology Evading Apoptosis to Promote Persistent Infection

Nancy R. Gough

Science Signaling, AAAS, Washington, DC 20005, USA

Human immunodeficiency virus (HIV), which causes AIDS, is a persistent infection of T cells and can lead to cell death by apoptosis, which contributes to the compromised immune response. However, as a persistent infection, HIV has also developed strategies to prevent all infected cells from undergoing apoptosis. Schnepple et al. identified one such mechanism of evasion of apoptosis by showing that infected T cells produce a short form of the proapoptotic ligand TRAIL, which is a member of the tumor necrosis superfamily and interacts with five receptors. Two produce proapoptotic signals (TRAIL-R1 and TRAIL-R2), and three act as decoys and antagonize cell death (TRAIL-R3, TRAIL-R4, and ostoprotegrin). Infection of primary T cells from noninfected donors resulted in an increase in the abundance of TRAIL, TRAIL-R1, TRAIL-R2, and TRAIL-R4; however, viability was not increased when the cells were treated with a neutralizing antibody against TRAIL. Supernatants from infected T cells, but not uninfected cells, contained an 11-kD protein recognized by a polyclonal TRAIL antibody, and addition of supernatants from the infected cells to Jurkat T cells (a T cell line) reduced TRAIL-induced cell death. This 11-kD TRAIL protein (TRAIL-s, for TRAIL-short) was the result of alternative splicing of the TRAIL transcript in infected cells. Several independent assays demonstrated that TRAIL-s bound to TRAIL-R2 but not to TRAIL-R1. Stable expression of a tagged form of TRAIL-s in Jurkat cells reduced cell death in response to exogenous TRAIL, and knocking down TRAIL-s in one of these TRAIL-s–expressing cell lines enhanced TRAIL-induced cell death. To confirm the in vivo relevance of TRAIL-s, the authors showed that the abundance of TRAIL-s was higher in sera from HIV-infected patients and the amount correlated with viral load. Thus, production of an antagonistic form of TRAIL appears to contribute to survival of HIV-infected T cells and may contribute to viral persistence.

D. J. Schnepple, B. Shepard, G. D. Bren, N. W. Cummins, S. Natesampillai, S. Trushin, A. Algeciras-Schimnich, X. W. Meng, A. M. Sainski, S. A. Rizza, S. H. Kaufmann, A. D. Badley, Isolation of a TRAIL antagonist from the serum of HIV-infected patients. J. Biol. Chem. 286, 35742–35754 (2011). [Abstract] [Full Text]

Citation: N. R. Gough, Evading Apoptosis to Promote Persistent Infection. Sci. Signal. 4, ec293 (2011).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882